MADISON, Wis. (AP) -- A California company hopes to use stem cell technology developed at the University of Wisconsin-Madison to make new medical and research products.
BioTime, Inc. has signed a licensing agreement with the Wisconsin Alumni Research Foundation to use 173 patents and patent applications covering human embryonic stem cell technology.
The patents cover some of the work of UW-Madison scientist James Thomson.
Embryonic stem cells can turn into any type of cell in the body, and BioTime plans to develop products that help scientists do that.
CEO Michael West says the cells could then be used in research for cures to disease and to develop new drugs.
(Copyright 2008 by The Associated Press. All Rights Reserved.)